ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,048Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 2456

$601K Total Retail Price of All Prescriptions

Rank: 157 out of 2456

593 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 593 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 593 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 10,497 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 637 514 1 1
SIMVASTATIN 544 481 2 2
WARFARIN SODIUM 544 524 2 9
ATENOLOL 413 349 4 6
AMLODIPINE BESYLATE 404 373 5 5
OMEPRAZOLE 397 320 6 3
LEVOTHYROXINE SODIUM 334 306 7 4
HYDROCHLOROTHIAZIDE 332 302 8 7
FUROSEMIDE 249 226 9 8
TRAZODONE HCL 244 207 10 17
METOPROLOL TARTRATE 228 213 11 10
HYDROCODONE-ACETAMINOPHEN 225 116 S3 12 20
OXYCODONE-ACETAMINOPHEN 202 104 S2 13 35
PRAVASTATIN SODIUM 202 180 13 15
CITALOPRAM HBR 192 172 15 14
TRAMADOL HCL 184 124 16 24
ZOLPIDEM TARTRATE 156 96 17 28
LOVASTATIN 151 123 18 34
DONEPEZIL HCL 150 150 19 23
METFORMIN HCL 149 120 20 11
GABAPENTIN 147 107 21 16
CYCLOBENZAPRINE HCL 146 117 R 22 77
ATORVASTATIN CALCIUM 143 122 23 12
AZITHROMYCIN 122 82 24 60
FLUTICASONE PROPIONATE 122 94 24 30
LOSARTAN POTASSIUM 116 102 26 18
GLYBURIDE 110 77 R 27 40
FLUOXETINE HCL 110 75 27 45
LEVOFLOXACIN 100 82 29 103
METOPROLOL SUCCINATE 98 96 30 13
CIPROFLOXACIN HCL 97 83 31 87
SERTRALINE HCL 97 81 31 21
AMITRIPTYLINE HCL 95 79 R 33 83
PANTOPRAZOLE SODIUM 95 77 33 37
PREDNISONE 94 70 35 39
ALENDRONATE SODIUM 86 86 36 19
IBUPROFEN 86 58 36 52
FINASTERIDE 84 84 38 66
TAMSULOSIN HCL 83 83 39 32
LANTUS 82 44 40 44
OXYCODONE HCL 82 35 S2 40 38
CLOPIDOGREL 81 68 42 55
GLIPIZIDE 81 72 42 46
RANITIDINE HCL 80 52 44 31
PROAIR HFA 74 33 45 22
ADVAIR DISKUS 73 55 46 36
LORAZEPAM 72 72 47 67
POTASSIUM CHLORIDE 68 44 48 33
CEPHALEXIN 67 57 49 153
NAMENDA 67 64 49 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 48 51 41
CARBIDOPA-LEVODOPA 64 64 51 82
DIGOXIN 63 63 53 49
VERAPAMIL ER 62 61 54 91
CARISOPRODOL 61 25 R 55 179
MIRTAZAPINE 59 50 56 29
PLAVIX 59 55 56 79
CELEBREX 57 40 58 127
INSULIN SYRINGE 53 19 59 72
TRIAMTERENE-HCTZ 52 48 60 53
HYDRALAZINE HCL 52 50 60 105
SPIRIVA 52 48 60 43
ISOSORBIDE MONONITRATE ER 52 52 60 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.